Please login to the form below

Not currently logged in
Email:
Password:

Merck Serono

This page shows the latest Merck Serono news and features for those working in and with pharma, biotech and healthcare.

Lundbeck drops Parkinson’s drug acquired in €905m deal

Lundbeck drops Parkinson’s drug acquired in €905m deal

Lundbeck paid 100m upfront for Merck Serono spinout Pexton and foliglurax two years ago, with another 805m tied to  development and sales milestones.

Latest news

More from news
Approximately 21 fully matching, plus 136 partially matching documents found.

Latest Intelligence

  • The search for treatments for Parkinson’s disease The search for treatments for Parkinson’s disease

    and a decade as senior director of neurodegenerative diseases research at Merck Serono where he served as its leader for in vitro pharmacology in neurology, including in multiple sclerosis, Parkinson’s

  • A rare opportunity A rare opportunity

    The disappearance of that opportunity combined with changes at Merck following its 10.6bn acquisition of Serono gave Neil the momentum to set up his own consultancy business in 2007. ... He worked for a number of pharma clients, including Eisai and Merck

  • Sustainable solutions Sustainable solutions

    Over the summer Alex was appointed chair of the EMG, taking over from Merck' Serono's David Garmon-Jones, and he says both the EMG and its wider, UK industry counterpart ... In May 2014 it paid $14.2bn for Merck &Co's consumer health unit.

  • Deal Watch October 2015 Deal Watch October 2015

    This month's deal between Merck Serono (Merck KGaA) and BioMarin is a good example of this approach. ... Acquisition - company. 580. Merck Serono/ BioMarin. Kuvan and pegvaliase (Kuvan marketed; pegvaliase p3).

  • A bright future for OTC and Merck Consumer Health A bright future for OTC and Merck Consumer Health

    For Merck's Consumer Health business, change and growth in operations has also been driven by the incorporation of new brands, transferred from Merck Serono. ... In the longer term, Merck Consumer Health aspires to break the ¤1bn income barrier through

More from intelligence
Approximately 1 fully matching, plus 20 partially matching documents found.

Latest appointments

More from appointments
Approximately 5 fully matching, plus 32 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 10 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Iguazu

Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics